French recommendations for the management of Takayasu’s arteritis

David Saadoun (1, 2) , Alessandra Bura-Riviere (3) , Chloé Comarmond (2) , Marc Lambert (2, 4) , Alban Redheuil (2) , Tristan Mirault (5) , Eric Hachulla (6) , Pierre-Yves Hatron (7) , Hélène Maillard (7)

1 I3 - Immunologie - Immunopathologie - Immunothérapie [CHU Pitié Salpêtrière]
2 CHU Pitié-Salpêtrière [AP-HP]
3 CHU Toulouse - Centre Hospitalier Universitaire de Toulouse
4 RID-AGE - Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167
5 HEGP - Hôpital Européen Georges Pompidou [APHP]
6 INFINITE (Ex-Liric) - Institute for Translational Research in Inflammation - U 1286
7 LIRIC - Lille Inflammation Research International Center - U 995

The aim of this National Diagnostic and Care Protocol (PNDS) is to explain to the professionals involved the current optimal diagnosis and therapeutic management and care approach for a patient with Takayasu's arteritis. Its purpose is to optimize and harmonize the management and follow-up of this rare disease throughout the country. It also identifies pharmaceutical specialties used in an indication not provided for in the Marketing Authorization, as well as the specialties, products or services necessary for the care of patients but not usually paid for or reimbursed.

Domaines: Médecine humaine et pathologie

David Saadoun, Alessandra Bura-Riviere, Chloé Comarmond, Marc Lambert, Alban Redheuil, et al.. French recommendations for the management of Takayasu’s arteritis. Orphanet Journal of Rare Diseases, 2021, 16 (S3), p.311. ⟨10.1186/s13023-021-01922-1⟩. ⟨hal-03342825v2⟩